Mizuho Securities analyst Irina Koffler offered some comments on the specialty pharmaceutical sector give the panic following reports of fraud ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE